Literature DB >> 8567755

Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes.

N Meisler1, S Shull, R Xie, G L Long, M Absher, J P Connolly, K R Cutroneo.   

Abstract

Glucocorticoids have previously have shown to decrease Type I collagen synthesis in vivo and in fibroblast cell culture. Several studies have demonstrated that glucocorticoids decrease Type I procollagen gene expression. These latter studies have included uridine incorporation into pro alpha 1 (I) and pro alpha 2 (I) mRNAs and nuclear run-off experiments. Using the ColCat 3.6 plasmid, which contains part of the 5' flanking region of the pro alpha 1 (I) collagen gene and the reporter gene, chloramphenicol acetyltransferase, the present studies demonstrate by stable transfection of fetal rat skin fibroblasts that dexamethasone down regulates the promoter activity of the pro alpha 1 (I) collagen gene. The glucocorticoid-mediated down-regulation of procollagen gene expression was demonstrated using the ColCat 3.6, 2.4, 1.7, or 0.9 plasmid. In addition, competitive oligonucleotide transfection experiments and site specific mutation of the glucocorticoid response element (GRE) in the whole ColCat 3.6 plasmid did not eliminate the effect. The possibility existed that another cis-element in the 5' flanking region of the pro alpha 1 (I) collagen gene was also required for the collagen glucocorticoid-mediated down-regulation of procollagen gene expression, since TGF-beta has been shown to stimulate in a decrease of transforming growth factor-beta (TGF-beta) secretion into the media. Gel mobility studies demonstrated that glucocorticoid treatment of rat skin fibroblasts decreased glucocorticoid receptor binding to the GRE and TGF-beta activator protein to the TGF-beta element which were brought back to control values by coordinate exogenous TGF-beta treatment. Thus the interaction of these TGF-beta molecules with cellular membrane receptors and subsequent transduction is dramatically decreased resulting in less signals to regulate collagen gene expression. These data indicate that glucocorticoids coordinately regulate procollagen gene expression through both the GRE and TGF-beta elements. Depression of procollagen gene expression by glucocorticoids through the TGF-beta element is mediated by decreased TGF-beta secretion, possibly involving a secondary effect on regulatory protein(s) encoded by noncollagenous protein gene(s). The present studies provide the basis for a novel mechanism of glucocorticoid-mediator regulation of eukaryotic genes containing the TGF-beta element.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567755     DOI: 10.1002/jcb.240590309

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.

Authors:  Monica L Watson; Leslie M Baehr; Holger M Reichardt; Jan P Tuckermann; Sue C Bodine; J David Furlow
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-21       Impact factor: 4.310

Review 2.  Skin manifestations of Cushing's syndrome.

Authors:  Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

3.  The unexpected anabolic phenotype and extended longevity of skin fibroblasts after chronic glucocorticoid excess.

Authors:  Harris Pratsinis; Stylianos Tsagarakis; Irene Zervolea; Dimitri Stathakos; Nikos Thalassinos; Dimitris Kletsas
Journal:  Dose Response       Date:  2006-08-19       Impact factor: 2.658

4.  Molecular skin changes in Cushing syndrome and the effects of treatment.

Authors:  Z Karaca; S Taheri; S T Firat; M Borlu; G Zararsiz; E Mehmetbeyoglu; A Sezgin Caglar; A Hacioglu; F Tanriverdi; K Unluhizarci; F Kelestimur
Journal:  J Endocrinol Invest       Date:  2020-05-14       Impact factor: 4.256

5.  Inhibitory Effects of Prunella vulgaris L. Extract on 11β-HSD1 in Human Skin Cells.

Authors:  Kyung-Baeg Roh; Deokhoon Park; Eunsun Jung
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-04       Impact factor: 2.629

6.  Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis.

Authors:  Christoph Anacker; Annamaria Cattaneo; Alessia Luoni; Ksenia Musaelyan; Patricia A Zunszain; Elena Milanesi; Joanna Rybka; Alessandra Berry; Francesca Cirulli; Sandrine Thuret; Jack Price; Marco A Riva; Massimo Gennarelli; Carmine M Pariante
Journal:  Neuropsychopharmacology       Date:  2012-12-06       Impact factor: 7.853

7.  11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis.

Authors:  Tiina Kipari; Patrick W F Hadoke; Javaid Iqbal; Tak-Yung Man; Eileen Miller; Agnes E Coutinho; Zhenguang Zhang; Katie M Sullivan; Tijana Mitic; Dawn E W Livingstone; Christopher Schrecker; Kay Samuel; Christopher I White; M Amine Bouhlel; Giulia Chinetti-Gbaguidi; Bart Staels; Ruth Andrew; Brian R Walker; John S Savill; Karen E Chapman; Jonathan R Seckl
Journal:  FASEB J       Date:  2013-01-09       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.